Thomas J. Schall

Director, Immuneering Corp

Bought, 12 months

$0.1M

Sold, 12 months

$0.0M

Companies

Latest trade

Jan 15, 2026

Companies

Immuneering CorpDirector +$0.1M

Trades

IMRX Bought 21,645 shares at $4.67 $0.1M Jan 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.